RECENT DEVELOPMENTS IN THE TOXICOLOGY OF ANABOLIC-STEROIDS

被引：28

作者：

GRAHAM, S ^{[1
]}

KENNEDY, M ^{[1
]}

机构：

[1] CONCORD REPATRIAT GEN HOSP,CONCORD,NSW,AUSTRALIA

来源：

DRUG SAFETY | 1990年 / 5卷 / 06期

关键词：

D O I：

10.2165/00002018-199005060-00007

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Anabolic steroids are extensively abused as ergogenic aids by athletes (and others). A number of features of anabolic steroid use and toxicology have been recently reviewed in the Journal, and a large body of data has accumulated concerning their toxic nature. The lipoprotein profile induced by anabolic steroids carries a markedly adverse cardiovascular risk. Glucose metabolism is significantly altered and includes peripheral insulin resistance, hyperinsulinaemia and attenuated responses to glucagon. Hypertension has been noted. Psychiatric and psychological alterations are major toxicities of anabolic steroids, and probably constitute the major mechanism of their action. Hepatic neoplasia occurs in the setting of abuse of this class of drugs, and may be related to their use, although there is no convincing evidence that other malignancies are induced in athletes who abuse them. Gross disturbance of reproductive function occurs in both sexes: hypogonadal states are common and prolonged. The anabolic steroids are toxic drugs with both long and short term effects. Their abuse by athletes is to be decried, particularly in view of the frequent and prolonged use by the young. © 1990, Adis International Limited. All rights reserved.

引用

页码：458 / 476

页数：19

共 205 条

[11]

Bhargava K.P., Dhawan K.N., Sazena R.C., Enhancement of nor-adrenaline pressor responses in testosterone treated cats, British Journal of Pharmacology and Chemotherapy, 31, pp. 26-31, (1967)

[12]

Boel J., Andersen L.B., Rasmussen B., Et al., Hepatic drug metabolism and physical fitness, Clinical Pharmacology and Therapeutics, 36, pp. 121-126, (1984)

[13]

Bowman S.J., Tanna S., Fernando S., Ayodeji A., Weatherstone R.M., Anabolic steroids and infarction, British Medical Journal, 299, (1989)

[14]

Brower K.J., Blow F.C., Beresford T.P., Feulling C., Anabolic-andro-genic steroid dependence, Journal of Clinical Psychiatry, 50, pp. 31-33, (1989)

[15]

Brunner N., Landolt F., Zachmann M., Vortäuschung eines adren-ogenitalen Syndromes durch langdauernde Verabreichung an-aboler Steroidsalbe, Helvetica Paediatrics Acta, 32, (1974)

[16]

Buckley W.E., Yesalis C.E., Et al., Estimated prevalence of anabolic steroid use among male high school seniors, Journal of the American Medical Association, 260, pp. 3441-3445, (1988)

[17]

Cade J.F., Stubbs K.P., Stubbs A.E., Clegg E.A., Thrombosis, fibri-nolysis and ethylestrenol, Acta Endocrinologica, 271, pp. 53-59, (1985)

[18]

Calabrese L.H., Kleiner S.M., Barna B.P., Et al., The effects of anabolic steroids and strength training on the human immune response, Medicine and Science in Sports and Exercise, 21, pp. 386-392, (1989)

[19]

Chang W.C., Nakao J., Et al., Effects of testosterone on the metabolism of arachadonic acid by aortas and platelets in rats, Pros-taglandins Leukotrienes and Medicine, 9, pp. 495-501, (1982)

[20]

Cohen J.C., Hickman R., Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids, Journal of Clinical Endocrinology and Metabolism, 64, pp. 960-963, (1987)

← 1 2 3 4 5 6 7 8 9 10 →